(Q80539045)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

1 reference

2

Alice S Whittemore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Mindie H Nguyen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ruel T Garcia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Saraa A Tawfeek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jing Ning

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Suzanna Lam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Teresa L Wright

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Emmet B Keeffe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

Clinical Gastroenterology and Hepatology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

820-824

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Risk factors for the rising rates of primary liver cancer in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Screening for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatocellular carcinoma: an Asian perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Ethnic differences in the behavior of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900353-2

7 January 2021

10.1016/S1542-3565(04)00353-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15354283%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference